The World Anti-Microbial Resistance Congress USA gathers C-level decision makers from government, funding agencies, pharma, academia, hospitals, labs, and payers to discuss the urgent need for new antibiotics. As international attention continues to turn to the world's growing resistance to antibiotics, the need for new drugs and significant alternatives to existing ones grows as well. International organizations like WHO, which is running an awareness campaign, have begun to take notice and call for action.
This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This conference provides a platform for professionals in the antimicrobial resistance industry to answer the call.
The focus is shifting toward increasing speed and accuracy of patient diagnosis as a manner of alleviating the general need for antibiotics. With this shift in focus comes a need we've recognized in this space to provide a platform for leaders in the diagnostics and healthcare industries to discuss developments and improvements to help minimize the need for antibiotics and achieve effective diagnosis sooner.
Stewardship is the effort to prevent this improper use of drugs, aiming for optimizing everything prescription to duration of treatment to administration of treatment. Much like diagnostics, stewardship provides a potential solution to this growing problem alternative to new antibiotic development.
We've outgrown the space at our tried and true venue, and we've found a spot that leaves us with room to grow! Next year's venue, The JW Marriott will offer more space and give us the opportunity to make World Anti-Microbial Resistance Congress USA bigger and better than ever!
This is the opportunity to pitch your new antibiotic or treatment alternative to those who are looking for the next promising developments in fighting AMR.
Presentations will be made in the areas of both antibiotic development and stewardship, highlighting the latest advances in both new antibiotics and alternative therapies for drug-resistant infections.
This is the chance to meet the right people who can set your research on the path to development and success. Take the opportunity to display what you've been working on to those who can truly be instrumental in setting development for your antibiotic or therapy in motion.